For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent ...

Recently, to my surprise, I came down with bladder cancer. I am a healthy 66-year-old man who is 5 feet, 11 inches tall, 215 ...

As global interest in weight loss remedies grows, the off-label use of diabetes medication Ozempic for shedding pounds in non ...

Don’t be persuaded by the abundance of propaganda you see in ads, newspapers, magazines, TV, and the Internet. There is no ...

Stopping the widespread use of unnecessary, potentially even harmful, cancer screenings can take up to 13 years and ...

WOMEN on fat jabs must take effective contraception, health chiefs have warned for the first time. It comes amid claims of an ...

EVERYONE’S talking about fat jabs – the ‘miracle’ injections trimming inches off waistlines, and helping turn the tide on the ...

And GLP-1 agonists were associated with an 8% lower mortality risk as well (HR 0.92, 95% CI 0.87-0.97), according to findings presented during a press briefing ahead of the Americ ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...

there has been no association ever with any increased risk of thyroid cancer with GLP-1 drugs.” Whether you have thyroid cancer and are wondering about — or already taking — a GLP-1 medication (like ...

"The SURMOUNT-5 head-to-head results demonstrated tirzepatide led to greater weight reduction compared to semaglutide ... cause tumors in the thyroid, including thyroid cancer.

Warnings - Zepbound may cause tumors in the thyroid, including thyroid cancer. Watch for possible ... Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if ...